1. Shankar-Hari M, Rubenfeld GD. Understanding long-term outcomes following sepsis: Implications and challenges. Curr Infect Dis Rep 2016;18:37. https://doi.org/10.1007/s11908-016-0544-7 |
|
2. Berg D, Gerlach H. Recent advances in understanding and managing sepsis. F1000Res 2018;7:1570. https://doi.org/10.12688/f1000research.15758.1 | |
|
3. Serrano I, Luque A, Aran JM. Exploring the immunomodulatory moonlighting activities of acute phase proteins for tolerogenic dendritic cell generation. Front Immunol 2018;9:892. https://doi.org/10.3389/fimmu.2018.00892 | |
|
4. Schrödl W, Büchler R, Wendler S, Reinhold P, Muckova P, Reindl J, et al. Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine. Prot Clin Appl 2016;10:1077-92. https://doi.org/10.1002/prca.201600028 | |
|
5. Jekarl DW, Kim JY, Lee S, Kim M, Kim Y, Han K, et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: A multiplex analysis. Clin Chem Lab 2015;53:575-81. https://doi.org/10.1515/cclm-2014-0607 | |
|
6. da Gomes Cunha DM, da Silva GG, Hamasaki MY. New biomarkers of sepsis with clinical relevance. In: Stawicki P, Swaroop S, editors. Clinical Management of Shock the Science and Art of Physiological Restoration. London: IntechOpen; 2020. Available from: https://www.intechopen.com/books/clinical-management-of-shock-the-science-and-art-of-physiological-restoration/new-biomarkers-of-sepsis-with-clinical-relevance [Last accessed on 2022 Feb 17]. https://doi.org/10.5772/intechopen.82156 | |
|
7. Nelson GE, Mave V, Gupta A. Biomarkers for sepsis: A review with special attention to India. Biomed Res Int 2014;2014:264351. https://doi.org/10.1155/2014/264351 | |
|
8. Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev 2017;38:59-68. | |
|
9. Mårtensson J, Bell M, Xu S, Bottai M, Ravn B, Venge P, et al. Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction. Biomarkers 2013;18:349-56. https://doi.org/10.3109/1354750X.2013.787460 | |
|
10. Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M. Comparative assessment of neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early biomarker for early detection of renal failure in patient with hypertension Iran Biomed J 2015;19:76-81. | |
|
11. Mårtensson J, Bellomo R. The rise and fall of NGAL in acute kidney injury. Blood Purif 2014;37:304-10. https://doi.org/10.1159/000364937 | |
|
12. Helanova K, Spinar J, Parenica J. Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases review. Kidney Blood Press Res 2014;39:623-9. https://doi.org/10.1159/000368474 | |
|
13. Siddappa PK, Kochhar R, Sarotra P, Medhi B, Jha V, Gupta V. Neutrophil gelatinase-associated lipocalin: An early biomarker for predicting acute kidney injury and severity in patients with acute pancreatitis. JGH Open 2019;3:105-10. https://doi.org/10.1002/jgh3.12112 | |
|
14. Otto GP, Hurtado-Oliveros J, Chung HY, Knoll K, Neumann T, Müller HJ, et al. Plasma neutrophil gelatinase-associated lipocalin is primarily related to inflammation during sepsis: A translational approach. PLoS One 2015;10:e0124429. https://doi.org/10.1371/journal.pone.0124429 | |
|
15. Nasioudis D, Witkin SS. Neutrophil gelatinase-associated lipocalin and innate immune responses to bacterial infections. Med Microbiol Immunol 2015;204:471-9. https://doi.org/10.1007/s00430-015-0394-1 | |
|
16. Jonsson N, Gille-Johnson P, Martling CR, Xu S, Venge P, Mårtensson J. Performance of plasma measurement of neutrophil gelatinase-associated lipocalin as a biomarker of bacterial infections in the intensive care unit. J Crit Care 2019;53:264-70. https://doi.org/10.1016/j.jcrc.2019.07.001 | |
|
17. Walvik L, Kirchmann M, Jensen CA, Kristiansen S, Hansen LF, Howitz MF. Neutrophil gelatinase associated lipocalin a biomarker for bacterial-induced pharyngeal infection a pilot study. Clin Exp Dent Res 2020;6:433-8. https://doi.org/10.1002/cre2.295 | |
|
18. Bao GH, Ho CT, Barasch J. The ligands of neutrophil gelatinase-associated lipocalin. RSC Adv 2015;5:104363-74. https://doi.org/10.1039/C5RA18736B | |
|
19. Chakraborty S, Kaur S, Tong Z, Batra SK, Guh S. Neutrophil gelatinase associated lipocalin: structure, function and role in human pathogenesis. In: Veas F, editor. Acute Phase Proteins Regulation and Functions of Acute Phase Proteins. London: InTech; 2011. Available from: http://www.intechopen.com/books/acute-phase-proteins-regulation-and-functions-of-acute-phase-proteins/neutrophil-gelatinase-associated-lipocalin-structure-function-and-role-in-human-pathogenesis [Last accessed on 2022 Feb 18]. https://doi.org/10.5772/18755 | |
|
20. Jaberi SA, Cohen A, D'Souza C, Abdulrazzaq YM, Ojha S, Bastaki S, et al. Lipocalin-2: Structure, function, distribution and role in metabolic disorders. Biomed Pharmacother 2021;142:112002. https://doi.org/10.1016/j.biopha.2021.112002 | |
|
21. Passov A, Ilmakunnas M, Pihlajoki M, Hermunen K, Lempinen M, Helanterä I, et al. Neutrophil gelatinase-associated lipocalin does not originate from the kidney during reperfusion in clinical renal transplantation. ICMx 2021;9:56. https://doi.org/10.1186/s40635-021-00422-7 | |
|
22. Belcher JM, Parikh CR. Acute kidney injury diagnostics and biomarkers. In: Chronic Kidney Disease, Dialysis, and Transplantation. Amsterdam, Netherlands: Elsevier; 2019. p. 713- 24.e5. Available from: https://linkinghub.elsevier.com/retrieve/pii/ B9780323529785000471 [Last accessed on 2022 Feb 18]. https://doi.org/10.1016/B978-0-323-52978-5.00047-1 | |
|
23. Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 2012;1826:129-69. https://doi.org/10.1016/j.bbcan.2012.03.008 | |
|
24. Gouweleeuw L, Naudé PJ, Rots M, DeJongste MJ, Eisel UL, Schoemaker RG. The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease. Brain Behav Immun 2015;46:23-32. https://doi.org/10.1016/j.bbi.2014.12.026 | |
|
25. Cruz DN, Gaiao S, Maisel A, Ronco C, Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: A systematic review. Clin Chem Lab Med 2012;50:1533-45. https://doi.org/10.1515/cclm-2012-0307 | |
|
26. Miethke M, Skerra A. Neutrophil gelatinase-associated lipocalin expresses antimicrobial activity by interfering with l -norepinephrine-mediated bacterial iron acquisition. Antimicrob Agents Chemother 2010;54:1580-9. https://doi.org/10.1128/AAC.01158-09 | |
|
27. Bakhshandeh Z, Halabian R, Fooladi AA, Jahanian-Najafabadi A, Jalili MA, Roudkenar MH. Recombinant human lipocalin 2 acts as an antibacterial agent to prevent platelet contamination. Hematology 2014;19:487-92. https://doi.org/10.1179/1607845414Y.0000000155 | |
|
28. Yigit IP, Celiker H, Dogukan A, Ilhan N, Gurel A, Ulu R, et al. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter? Ren Fail 2015;37:77-82. https://doi.org/10.3109/0886022X.2014.975133 | |
|
29. Choi JW, Fujii T, Fujii N. Elevated plasma neutrophil gelatinase-associated lipocalin level as a risk factor for anemia in patients with systemic inflammation. Biomed Res Int 2016;2016:9195219. https://doi.org/10.1155/2016/9195219 | |
|
30. Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Interleukin-6 in surgery, trauma, and critical care Part II: Clinical implications. J Intensive Care Med 2011;26:73-87. https://doi.org/10.1177/0885066610384188 | |
|
31. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta- analysis. Lancet Infect Dis 2013;13:426-35. https://doi.org/10.1016/S1473-3099(12)70323-7 | |
|
32. Lippi G, Meschi T, Nouvenne A, Mattiuzzi C, Borghi L. Neutrophil gelatinase-associated lipocalin in cancer. In: Advances in Clinical Chemistry. Amsterdam, Netherlands: Elsevier; 2014. p. 179-219. https://doi.org/10.1016/B978-0-12-800263-6.00004-5 | |
|
33. Bolignano D, Coppolino G, Donato V, Lacquaniti A, Bono C, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL): A new piece of the anemia puzzle? Med Sci Monit Int Med J Exp Clin Res 2010;16:RA131-5. | |
|
34. Otto GP, Busch M, Sossdorf M, Claus RA. Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis. Crit Care 2013;17:419. https://doi.org/10.1186/cc12540 | |
|
35. Vijayan AL, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R, et al. Procalcitonin: A promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care 2017;5:51. https://doi.org/10.1186/s40560-017-0246-8 | |
|
36. Smertka M, Wroblewska J, Suchojad A, Majcherczyk M, Jadamus- Niebroj D, Owsianka-Podlesny T, et al. Serum and urinary NGAL in septic newborns. Biomed Res Int 2014;2014:717318. https://doi.org/10.1155/2014/717318 | |
|
37. Macdonald SPJ, Stone SF, Neil CL, van Eeden PE, Fatovich DM, Arendts G, et al. Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department. PLoS One 2014;9:e110678. https://doi.org/10.1371/journal.pone.0110678 | |
|
38. Schley G, Köberle C, Manuilova E, Rutz S, Forster C, Weyand M, et al. Comparison of plasma and urine biomarker performance in acute kidney injury. PLoS One 2015;10:e0145042. https://doi.org/10.1371/journal.pone.0145042 | |
|
39. Suuronen T, Nuutinen T, Huuskonen J, Ojala J, Thornell A, Salminen A. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm Res 2005;54:194-203. https://doi.org/10.1007/s00011-005-1343-z | |
|
40. Bianchi VE. The Anti-inflammatory effects of testosterone. J Endocr Soc 2019;3:91-107. https://doi.org/10.1210/js.2018-00186 | |
|
41. Hall OJ, Klein SL. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol 2017;10:1097-107. https://doi.org/10.1038/mi.2017.35 | |
|
42. RIddell SR. Adrenaline fuels a cytokine storm during immunotherapy. Nature 2018;564:194-6. https://doi.org/10.1038/d41586-018-07581-w | |
|
43. Nadia ME, Nazrun AS, Norazlina M, Isa NM, Norliza M, Nirwana SI. The anti-inflammatory, phytoestrogenic, and antioxidative role of Labisia pumila in prevention of postmenopausal osteoporosis. Adv Pharmacol Sci 2012;2012:706905. https://doi.org/10.1155/2012/706905 | |
|
44. Song CH, Kim N, Kim DH, Lee HN, Surh YJ. 17-β estradiol exerts anti-inflammatory effects through activation of Nrf2 in mouse embryonic fibroblasts. PLoS One 2019;14:e0221650. https://doi.org/10.1371/journal.pone.0221650 | |
|
45. Hunsu VO, Facey CO, Fields JZ, Boman BM. Retinoids as chemo-preventive and molecular-targeted anti-cancer therapies. Int J Mol Sci 2021;22:7731. https://doi.org/10.3390/ijms22147731 | |
|
46. Chakrabarty M, Datta GK, Ghosh S, Debnath PK. Induction of antioxidative enzyme by the ayurvedic herb Desmotrichum fimbriatum Bl. in mice. Indian J Exp Biol 2001;39:485-6. | |
|
47. Han M, Li Y, Wen D, Liu M, Ma Y, Cong B. NGAL protects against endotoxin-induced renal tubular cell damage by suppressing apoptosis. BMC Nephrol 2018;19:168. https://doi.org/10.1186/s12882-018-0977-3 | |